Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,035
datasets available to search
ShareScore release 0.9.0
Dataset results
1,035 results for “cancer invasion”
Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)
ClinicalTrials.gov study NCT04134000. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)
ClinicalTrials.gov study NCT06214793. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Neo-adjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Squamous Cell Esophageal Cancer
ClinicalTrials.gov study NCT02188615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)
ClinicalTrials.gov study NCT01094496. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors
ClinicalTrials.gov study NCT03980509. IPD Sharing: NO. Countries: 1. Publications: 0.
Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT06187506. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT05327647. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment of High-risk Non-muscle Invasive Bladder Cancer With IMUNO BGC Moreau RJ as Prophylaxis
ClinicalTrials.gov study NCT03982797. IPD Sharing: NO. Countries: 1. Publications: 0.
OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT05232136. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial
ClinicalTrials.gov study NCT07332351. IPD Sharing: NO. Countries: 1. Publications: 0.
A Prospective Multicenter Diagnostic Biomarker Study to Discriminate Borderline from Stage I Invasive Ovarian Cancer
ClinicalTrials.gov study NCT06709872. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT06919965. IPD Sharing: YES. Countries: 14. Publications: 0.
A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT06108492. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Dep
ClinicalTrials.gov study NCT07036731. IPD Sharing: YES. Countries: 1. Publications: 0.
Does Surface Tell us About the Invasive Front in Colorectal Cancer
ClinicalTrials.gov study NCT02002299. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Minimally Invasive Liver Surgery for Metastases From Colorectal Cancer: Oncologic Outcome and Prognostic Factors
ClinicalTrials.gov study NCT01356706. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer
ClinicalTrials.gov study NCT00135018. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT01295489. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Stimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102
ClinicalTrials.gov study NCT04109092. IPD Sharing: YES. Countries: 1. Publications: 0.
A Clinical Study of RC48-ADC Combined With Triplizumab For Treatment of Myometrial Invasive Bladder Cancer
ClinicalTrials.gov study NCT05016973. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.